Zdrowie i gospodarka · 08/09/1997
FDA Releases Draft Guidance on Hemoglobin- and Perfluorocarbon-Based Oxygen Carriers
The Food and Drug Administration (FDA) has made available a draft guidance document outlining the efficacy evaluation criteria for clinical trials of hemoglobin- and perfluorocarbon-based oxygen carrier products, aimed at manufacturers, investigators, and sponsors.
Source: Federal Register — Food and Drug AdministrationOpen original release →